Challenges in Oncology Clinical Trials

This chapter explores the intricate issues surrounding clinical trials in oncology, focusing on the high costs and modest benefits of new cancer drugs. It also discusses the significant biases introduced by pharmaceutical funding, the exclusion of typical patients from trials, and the ethical considerations in proving drug efficacy. Highlighting the need for transparency and systemic reform, the chapter underscores the importance of rigorous testing in ensuring meaningful patient outcomes.